SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-014879
Filing Date
2019-01-23
Accepted
2019-01-23 17:03:34
Documents
3
Period of Report
2019-01-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d695937d8k.htm 8-K 19674
2 EXHIBIT 99.1 d695937dex991.htm EX-99.1 7632
3 GRAPHIC g695937g91f88.jpg GRAPHIC 3334
  Complete submission text file 0001193125-19-014879.txt   33264
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 19537989
SIC: 2834 Pharmaceutical Preparations